Yerba Mate

Umxholo

• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

Iqabane le-Yerba sisityalo. Amagqabi asetyenziselwa ukwenza iyeza.

Abanye abantu bathatha iqabane ngomlomo ukukhulula ukudinwa engqondweni nasemzimbeni (ukudinwa), kunye nesifo esinganyangekiyo (FFS). Ikwafunyanwa ngomlomo kwizikhalazo ezinxulumene nentliziyo kubandakanya ukusilela kwentliziyo, ukubetha kwentliziyo okungagungqiyo, kunye noxinzelelo lwegazi.

Abanye abantu bakwathatha iqabane ngomlomo ukuphucula imo kunye nokudakumba; isifo seswekile; cholesterol ephezulu; amathambo abuthathaka (i-osteoporosis); Ukuphelisa iintlungu kunye neentlungu ezidibeneyo; ukunyanga usulelo lwe-urinary tract (UTIs), kunye nesinyi kunye namatye ezintso; ukunciphisa umzimba; nanjengeyeza lokuthambisa.

Ekutyeni, i-yerba mate isetyenziselwa ukwenza isiselo esifana neti.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe IYERBA MATE zezi zilandelayo:

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Ukusebenza kwezemidlalo. Uphando lwakwangoko lubonisa ukuba idosi enye ye-yerba iqabane ngaphambi kokuzilolonga inokunciphisa indlala ngaphambi kokuzivocavoca kunye nokuphucula imeko emva kokuzivocavoca kwabasetyhini. Olunye uphando lubonisa ukuba ukuthatha i-yerba iqabane lakho yonke imihla kwiintsuku ezi-5 kunokuphucula ukusebenza ngokuthobekileyo kwimidlalo yokubaleka.
• Imemori kunye nezakhono zokucinga (umsebenzi wokuqonda). Uphando lwakwangoko lubonisa ukuba ukusela isiselo esine-yerba mate akuphuculi inkumbulo, ixesha lokuphendula, okanye ukuchaneka kwengqondo kubantu basetyhini abasempilweni.
• Seswekile. Uphando lwakwangoko lubonisa ukuba ukusela i-yerba mate iti kathathu mihla le kwiintsuku ezingama-60 kungathoba iswekile yegazi kubantu abanesifo seswekile sesi-2.
• Amanqanaba aphezulu e-cholesterol okanye amanye amafutha (lipids) egazini (hyperlipidemia). Uphando lwakwangoko lubonisa ukuba iti yokusela ene-yerba iqabane kathathu mihla le kwiintsuku ezingama-40 inokuhlisa i-cholesterol iyonke kunye ne-lipoprotein (LDL okanye "embi") ye-cholesterol, kunye nokunyusa i-cholesterol ephezulu ye-lipoprotein (HDL okanye "elungileyo"), ebantwini ngecholesterol ephezulu. Oku kubandakanya abantu abasele bethatha iziyobisi ze-statin. Nangona kunjalo, olunye uphando lwakwangoko lubonisa ukuba i-yerba iqabane alitshintshi amanqanaba eepid kubantu abadala abane-HIV abangenayo i-cholesterol ephezulu.
• Ukutyeba kakhulu. Uphando lwakwangoko lubonisa ukuba ukuthatha iqabane ngomlomo kunganciphisa amanqatha kwaye kubangele ukuncipha xa kusetyenziswa wedwa okanye ngokudibanisa ne-guarana kunye nedamiana.
• Amathambo abuthathaka kunye nophuko (i-osteoporosis). Ukusela i-yerba mate tea yonke imihla ubuncinci iminyaka emi-4 kunokunciphisa izinga lokuphulukana nethambo kubafazi abasele besemva kokuya esikhathini. Nangona kunjalo, olunye uphando lubonisa ukuba i-yerba iqabane lingenakuba nasiphi na isiphumo kwinqanaba lokulahleka kwethambo kubafazi abasele besemva kokuya esikhathini.
• Isifo seswekile. Uphando lwakwangoko lubonisa ukuba ukusela i-yerba mate iti kathathu mihla le kwiintsuku ezingama-60 akukunciphisi ukuzila iswekile yegazi kubantu abane-prediabetes. Nangona kunjalo, inokunciphisa i-hemoglobin eglycated (HbA1C), umlinganiso weswekile yegazi.
• Ukudinwa okungapheliyo (i-CFS).
• Ukuqunjelwa.
• Uxinzelelo.
• Intloko ebuhlungu.
• Iimeko zentliziyo.
• Izintso kunye namatye esinyi.
• Uxinzelelo lwegazi oluphantsi.
• Usulelo lwe-Urinary tract (UTIs).
• Ezinye iimeko.

Ubungqina obuninzi buyafuneka ukukala ukusebenza kwe-yerba mate kwezi zinto zisetyenziswayo.

I-mate ye-Yerba iqulethe i-caffeine kunye nezinye iikhemikhali ezikhuthaza ubuchopho, intliziyo, izihlunu ezifake imithambo yegazi, kunye namanye amalungu omzimba. Xa ithathwa ngomlomo:I-Yerba iqabane li UKHUSELEKO OLUNOKWENZEKA kubantu abaninzi xa bethathwe ixesha elincinci. I-mate ye-Yerba iqulethe icaffeine, ethi kwabanye abantu ibangele iziphumo ebezingalindelekanga ezinje ngokungakwazi ukulala (ukuphuthelwa), ukoyika nokungazinzi, isisu esibuhlungu, isicaphucaphu nokugabha, ukunyuka kwentliziyo kunye nokuphefumla, kunye nezinye iziphumo ebezingalindelekanga.

I-Yerba iqabane li OKUNGENZEKA UKHUSELEKILE xa ithathwa ngesixa esikhulu okanye ixesha elide. Ukutya isixa esikhulu se-yerba iqabane (ngaphezulu kweekomityi ezili-12 mihla le) kunokubangela intloko, uxinzelelo, ukuphazamiseka, ukukhala ezindlebeni, kunye nokubetha kwentliziyo okungaqhelekanga. Ukusela isixa esikhulu se-yerba mate (i-1-2 yeelitha mihla le) kukonyusa umngcipheko wesifo somhlaza, umhlaza wezintso, umhlaza wesisu, umhlaza wesinyi, umhlaza wesibeleko, umhlaza webele, umhlaza wemiphunga, kunye nomhlaza welaryngeal okanye womlomo. Lo mngcipheko uphezulu ngokukodwa kubantu abatshayayo okanye abasela utywala.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Iqabane le-Yerba OKUNGENZEKA UKHUSELEKILE xa ithathwa ngomlomo ngexesha lokukhulelwa. Enye inkxalabo kukuba ukusebenzisa i-yerba mate kubonakala ngathi kukonyusa umngcipheko wokuba nomhlaza. Ayaziwa nokuba loo mngcipheko ugqithiselwe kumntwana osakhulayo. Enye inkxalabo ngumxholo weCaffeine we-yerba mate. I-caffeine inqumla i-placenta kwaye ingena kwigazi lomntwana, ivelisa amanqanaba e-caffeine kwimveku efana nenqanaba le-caffeine kunina. Ngokubanzi, oomama kufuneka bakuphephe ukusebenzisa ngaphezu kwe-300 mg ye-caffeine mihla le; imalunga neekomityi ezi-6 ze-yerba mate. Iintsana ezizalwe ngoomama abatya kakhulu icaffeine ngexesha lokukhulelwa ngamanye amaxesha zibonisa iimpawu zokurhoxiswa kwe-caffeine emva kokuzalwa. Iidosi eziphezulu zecaffeine zikwanxulunyaniswa nokuphuma kwesisu, ukuhanjiswa kwangaphambi kwexesha kunye nobunzima bokuzalwa. Nangona kunjalo, abaphandi bafundile oomama abasela i-yerba mate iti ngexesha lokukhulelwa kwaye abafumananga ikhonkco elinamandla phakathi kokusela i-yerba mate kunye nokuhanjiswa kwangaphambi kwexesha okanye ubunzima bokuzalwa obuncinci. Kodwa olu phononongo luye lwagxekwa kuba khange luqwalasele inani leerba mate okanye icaffeine esetyenziswa ngoomama; Kwajongwa kuphela ukuba bayisebenzisa kangaphi i-yerba mate.

I-Yerba iqabane nalo OKUNGENZEKA UKHUSELEKILE ngexesha lokuncancisa. Ayaziwa nokuba imichiza ebangela umhlaza kwi-yerba mate idlula kubisi lwebele, kodwa oko kuyinkxalabo. I-caffeine kwi-yerba mate nayo ingxaki. Inokubangela ukucaphuka kunye nokwanda kokuhamba kwamathumbu kwiintsana ezincancisayo.

Abantwana: Iqabane le-Yerba OKUNGENZEKA UKHUSELEKILE yabantwana xa bethathwe ngomlomo. I-Yerba iqabane linxulunyaniswa nomngcipheko okhulayo womhlaza wokuqina, umhlaza wezintso, umhlaza wesisu, umhlaza wesinyi, umhlaza wesibeleko, umhlaza webala, umhlaza wemiphunga, kunye nomhlaza welaryngeal okanye womlomo.

Utywala: Ukusetyenziswa kotywala kakhulu kunye nokudibanisa ukusetyenziswa kwe-yerba yexesha elide kwandisa umngcipheko womhlaza ukusuka kathathu ukuya ku-7.

Ukuxhalaba: I-caffeine kwi-yerba iqabane inokwenza ukuba uxinzelelo lube nzima ngakumbi.

Iingxaki zokopha: I-caffeine inokucotha ukujiya. Ngenxa yoko, kukho inkxalabo yokuba i-caffeine kwi-yerba mate inokwenza ukuba ukuphazamiseka kwegazi kube kubi ngakumbi. Kodwa ukuza kuthi ga ngoku, lempembelelo ayikhange ixelwe ebantwini.

Iimeko zentliziyo: I-caffeine kwi-yerba iqabane inokubangela ukubetha kwentliziyo ngokungafaniyo kubantu abathile. Ukuba unesifo sentliziyo, xoxa ngokusebenzisa iqabane lakho kunye nomboneleli wakho wezempilo.

Seswekile: Olunye uphando lubonisa ukuba i-caffeine kwi-yerba mate inokuchaphazela indlela abantu abanesifo seswekile abenza ngayo iswekile kwaye inokuba nzima kulawulo lweswekile yegazi. Kukho nolunye uphando olunomdla olubonisa i-caffeine inokwenza ukuba isilumkiso seswekile esezantsi yegazi kubantu abane-1 yeswekile ibonakale. Olunye uphononongo lubonisa ukuba iimpawu zeswekile esezantsi yegazi ziba namandla ngakumbi xa ziqala ngokungabikho kwe-caffeine, kodwa njengoko iswekile esezantsi yegazi iqhubeka, iimpawu zikhulu ngecaffeine. Oku kunokunyusa amandla abantu abanesifo seswekile ukuba babone kwaye banyange iswekile esezantsi yegazi. Nangona kunjalo, icala eliphantsi kukuba icaffeine inokunyusa inani leziqwengana zeswekile esezantsi. Ukuba unesifo seswekile, thetha nomboneleli wakho wezempilo ngaphambi kokusebenzisa iqabane lakho.

Urhudo: Iqabane le-Yerba linecaffeine. I-caffeine kwi-yerba mate, ngakumbi xa ithathwa ngesixa esikhulu, inokulwenza lukhulu urhudo.

IglaucomaSebenzisa i-yerba iqabane lakho lonyusa uxinzelelo ngaphakathi kweliso ngenxa yecaffeine equlathe. Ukwanda koxinzelelo kwenzeka ngaphakathi kwimizuzu engama-30 kwaye kuhlala ubuncinci imizuzu engama-90. Ukuba une-glaucoma, xoxa ngokusetyenziswa kweqabane lakho kunye nomboneleli wakho wezempilo.

Igazi elonyukayo: Umlingane we-Yerba une-caffeine. Ukusela icaffeine kunokunyusa uxinzelelo lwegazi kubantu abanexinzelelo lwegazi. Nangona kunjalo, oku kunokuba kuncinci kubantu abasela icaffeine rhoqo.

Isifo sengqondo sesifo esibuhlungu (IBS): Umlingane we-Yerba une-caffeine. I-caffeine kwi-yerba mate, ngakumbi xa ithathwa ngesixa esikhulu, inokulwenza luluhle kakhulu urhudo kwaye inokuba mandundu kwiimpawu ze-IBS.

Amathambo angenamandla (i-osteoporosis): Abanye abaphandi bafumanise ukuba abafazi be-postmenopausal abasela iikomityi ezi-4 okanye nangaphezulu imihla ngemihla yeti ye-yerba ye-mate yaseMzantsi Melika banobuninzi beethambo. Kodwa olunye uphando lubonisa ukuba iqabane lomlingane alinakuba nasiphi na isiphumo kumathambo abantu ababhinqileyo abasemva kwemini. Kwakhona, i-caffeine kwi-yerba iqabane lithanda ukukhupha i-calcium ngaphandle komzimba kumchamo. Oku kunokuba negalelo kumathambo abuthathaka. Ukuba une-osteoporosis, nciphisa ukusetyenziswa kwe-caffeine ukuya ngaphantsi kwama-300 mg ngosuku (malunga neekomityi ezi-6 ze-yerba mate). Ukuthatha i-calcium eyongezelelweyo kunokunceda ekwenzeni i-calcium ekhutshiwe. Ukuba uphilile ngokubanzi kwaye ufumana ikhalsiyam eyaneleyo ekutyeni nasekuncediseni, ukuthatha ukuya kwi-400 mg ye-caffeine mihla le (malunga ne-8-10 yeekomityi ze-yerba mate) akubonakali kwandisa umngcipheko wokufumana i-osteoporosis. Abasetyhini be-Postmenopausal abanesimo esizuze ilifa esibagcina ekusebenziseni i-vitamin D ngokuqhelekileyo, kufuneka balumke ngakumbi xa usebenzisa i-caffeine.

Kukho abanye abantu basetyhini abasemngciphekweni okhethekileyo wamathambo abuthathaka. Aba bafazi banesimo esifa njengelifa esenza ukuba kube nzima kubo ukusebenzisa ivithamin D ngokufanelekileyo. Vitamin D isebenza nge calcium ukwakha amathambo omeleleyo. Aba bafazi kufuneka balumke ngakumbi ekunciphiseni isixa se-caffeine abayifumana kwi-yerba mate nakweminye imithombo.

Ukutshaya: Umngcipheko wokuba nomhlaza ngamaxesha ama-3 ukuya kwasi-7 aphezulu kubantu abatshayayo kwaye basebenzise iqabane ixesha elide.

Mkhulu

Sukuyithatha le indibaniselwano.

IiAmphetamines

Iziyobisi ezikhuthazayo ezinje ngeamphetamines zikhawulezisa inkqubo yeemvakalelo. Ngokukhawulezisa inkqubo ye-nervous, amayeza akhuthazayo anokukwenza uzive ujittery kwaye wandise ukubetha kwentliziyo yakho. I-caffeine kwi-yerba iqabane nayo inokukhawulezisa inkqubo ye-nervous. Ukuthatha iqabane lakho kunye neziyobisi ezikhuthazayo kunokubangela iingxaki ezinje ngokunyuka kwenqanaba lentliziyo kunye noxinzelelo lwegazi. Kunqande ukuthatha iziyobisi ezikhuthazayo kunye ne-yerba mate.

Cocaine

Iziyobisi ezikhuthazayo ezinje ngecocaine ikhawulezisa inkqubo yeemvakalelo. Ngokukhawulezisa inkqubo ye-nervous, amayeza akhuthazayo anokukwenza uzive ujittery kwaye wandise ukubetha kwentliziyo yakho. I-caffeine kwi-yerba iqabane nayo inokukhawulezisa inkqubo ye-nervous. Ukuthatha iqabane lakho kunye neziyobisi ezikhuthazayo kunokubangela iingxaki ezinje ngokunyuka kwenqanaba lentliziyo kunye noxinzelelo lwegazi. Kunqande ukuthatha iziyobisi ezikhuthazayo kunye ne-yerba mate.

Ephedrine

Iziyobisi ezikhuthazayo zikhawulezisa inkqubo yeemvakalelo. I-Caffeine (equlethwe kwi-yerba mate) kunye ne-ephedrine zombini iziyobisi ezikhuthazayo. Ukuthatha i-caffeine kunye ne-ephedrine kunokubangela ukhuthazo kakhulu kwaye ngamanye amaxesha kube neziphumo ebezingalindelekanga ezinzulu kunye neengxaki zentliziyo. Musa ukuthatha iimveliso ezine-caffeine kunye ne-ephedrine ngaxeshanye.

Iphakathi

Lumka ngale nhlanganisela.

Adenosine (Adenocard)

I-mate ye-Yerba iqulethe icaffeine. I-caffeine kwi-yerba mate inokuthintela iziphumo ze-adenosine (Adenocard). I-Adenosine (Adenocard) ihlala isetyenziswa ngoogqirha ukwenza uvavanyo entliziyweni. Olu vavanyo lubizwa ngokuba luvavanyo loxinzelelo lwentliziyo. Misa ukuchitha iqabane lomlingane okanye ezinye iimveliso ezinecaffeine ubuncinci iiyure ezingama-24 ngaphambi kovavanyo loxinzelelo lwentliziyo.

Iintsholongwane (iquinolone antibiotics)

I-mate ye-Yerba iqulethe icaffeine. Umzimba uyayaphula icaffeine kwi-yerba mate ukuze uyilahle. Amanye amayeza okubulala iintsholongwane anganciphisa ukuba umzimba uphula ngokukhawuleza njani na icaffeine. Ukuthatha la machiza kunye ne-caffeine kunokunyusa umngcipheko weziphumo ebezingalindelekanga kubandakanya ukonwaba, intloko ebuhlungu, ukubetha kwentliziyo, kunye nabanye.

Ezinye izibulala-zintsholongwane ezinciphisa ngokukhawuleza ukuba umzimba uphule i-caffeine zibandakanya i-ciprofloxacin (Cipro), gemifloxacin (Factive), levofloxacin (Levaquin), moxifloxacin (Avelox), ofloxacin (Floxin), kunye nezinye.

ICarbamazepine (iTegretol)

ICarbamazepine sisiyobisi esisetyenziselwa ukunyanga ukuxhuzula. I-caffeine inokunciphisa iziphumo ze-carbamazepine. Kuba i-yerba mate iqulethe icaffeine, ithiyori xa kuthathwa iqabane kunye ne-carbamazepine inokunciphisa iziphumo ze-carbamazepine kwaye inyuse umngcipheko wokubanjwa kwabanye abantu.

ICimetidine (iTagamet)

I-mate ye-Yerba iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Cimetidine (iTagamet) inokunciphisa ukuba umzimba wakho uyaphula ngokukhawuleza njani icaffeine. Ukuthatha i-cimetidine (Tagamet) kunye ne-yerba mate kunokunyusa amathuba okuba neziphumo ebezingalindelekanga ze-caffeine kubandakanya ukungcangcazela, intloko ebuhlungu, ukubetha kwentliziyo okukhawulezayo, kunye nabanye.

IClozapine (iClozaril)

Umzimba uyaphula i-clozapine (Clozaril) ukuze uyilahle. I-caffeine kwi-yerba mate ibonakala iyancipha ukuba umzimba uphula njani i-clozapine (Clozaril) ngokukhawuleza. Ukuthatha iqabane lakho kunye ne-clozapine (Clozaril) kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga ze-clozapine (Clozaril).

IDipyridamole (iPantantine)

I-mate ye-Yerba iqulethe icaffeine. I-caffeine kwi-yerba iqabane inokuthintela iziphumo ze-dipyridamole (Persantine). IDipyridamole (Persantine) ihlala isetyenziswa ngoogqirha ukwenza uvavanyo entliziyweni. Olu vavanyo lubizwa ngokuba luvavanyo loxinzelelo lwentliziyo. Misa ukuchitha iqabane lomlingane okanye ezinye iimveliso ezinecaffeine ubuncinci iiyure ezingama-24 ngaphambi kovavanyo loxinzelelo lwentliziyo.

Idisulfiram (iAntabuse)

Umzimba uyayaphula icaffeine ukuze uyilahle. I-Disulfiram (i-Antabuse) inokunciphisa ukuba umzimba ulahla njani ngokukhawuleza icaffeine. Ukuthatha iqabane lomlingani (eliqukethe i-caffeine) kunye ne-disulfiram (i-Antabuse) kunokunyusa imiphumo kunye nemiphumo emibi ye-caffeine kuquka ukuxhamla, ukunyanzeliswa, ukungabikho, kunye nabanye.

Estrogens

Umzimba wophula i-caffeine (equlethwe kwi-yerba mate) ukuze uyilahle. I-Estrogens inokunciphisa ngokukhawuleza ukuba umzimba uyaphula njani icaffeine. Ukwehla ukonakala kwe-caffeine kunokubangela ukothuka, intloko ebuhlungu, ukubetha kwentliziyo ngokukhawuleza, kunye nezinye iziphumo ebezingalindelekanga. Ukuba uthatha ii-estrogens, nciphisa umlinganiselo wakho wecaffeine.

Ezinye iipilisi ze-estrogen zibandakanya i-equine estrogens (Premarin), i-ethinyl estradiol, i-estradiol kunye nezinye.

I-Ethosuximide (iZarontin)

I-Ethosuximide sisiyobisi esisetyenziselwa ukunyanga ukuxhuzula. I-caffeine kwi-yerba mate inokunciphisa iziphumo ze-ethosuximide. Ukuthatha iqabane kunye ne-ethosuximide kunokunciphisa iziphumo ze-ethosuximide kunye nokunyusa umngcipheko wokubanjwa kwabanye abantu.

I-Felbamate (Felbatol)

I-Felbamate sisiyobisi esisetyenziselwa ukunyanga ukuxhuzula. I-caffeine kwi-yerba iqabane inokunciphisa iziphumo ze-felbamate. Ukuthatha iqabane kunye ne-felbamate kunokunciphisa iziphumo ze-felbamate kunye nokwandisa umngcipheko wokubanjwa kwabanye abantu.

IFlutamide (i-Eulexin)

Umzimba uqhekeza i-flutamide (i-Eulexin) ukuze uyilahle. I-caffeine kwi-yerba iqabane inokunciphisa ngokukhawuleza ukuba umzimba ulahle i-flutamide. Oku kunokubangela ukuba i-flutamide ihlale emzimbeni ixesha elide kwaye inyuse umngcipheko weziphumo ebezingalindelekanga.

IFluvoxamine (iLuvox)

Umzimba uyayaphula icaffeine kwi-yerba mate ukuze uyilahle. I-Fluvoxamine (Luvox) inganciphisa ukuba umzimba uphula njani ngokukhawuleza icaffeine. Ukuthatha iqabane iqabane kunye ne-fluvoxamine (Luvox) kunokubangela i-caffeine eninzi emzimbeni, kwaye yonyuse iziphumo kunye neziphumo ebezingalindelekanga ze-yerba mate.

ILithium

Umzimba wakho ngokwemvelo ulahla i-lithium. I-caffeine kwi-yerba mate inokunyusa ngokukhawuleza ukuba umzimba wakho ulahle i-lithium. Ukuba uthatha iimveliso eziqukethe i-caffeine kwaye uthatha i-lithium, yeka ukuthatha iimveliso ze-caffeine kancinci. Ukuyekisa iqabane lakho ngokukhawuleza kunokonyusa iziphumo ebezingalindelekanga ze-lithium.

Amayeza esifuba (i-Beta-adrenergic agonists)

I-mate ye-Yerba iqulethe icaffeine. I-caffeine inokuvuselela intliziyo. Amanye amayeza esifuba anokukhuthaza nentliziyo. Ukuthatha i-caffeine kunye namanye amayeza e-asthma kunokubangela ukuvuselela kakhulu kwaye kubangele iingxaki zentliziyo.

Amanye amayeza e-asthma afaka i-albuterol (Proventil, Ventolin, Volmax), metaproterenol (Alupent), terbutaline (Bricanyl, Brethine), isoproterenol (Isuprel), kunye nezinye.

Amayeza oxinzelelo (MAOIs)

I-caffeine kwi-yerba iqabane inokuvuselela umzimba. Amanye amayeza asetyenziselwa uxinzelelo anokuvuselela umzimba. Ukusela i-yerba iqabane kunye nokuthatha amayeza athile kuxinzelelo kunokubangela ukukhuthazeka okukhulu emzimbeni kunye neziphumo ebezingalindelekanga ezinzulu kubandakanya ukubetha kwentliziyo okukhawulezileyo, uxinzelelo lwegazi oluphezulu, uvalo kunye nokunye okunokwenzeka.

Amanye ala mayeza asetyenziselwa ukudakumba aquka i-rasagiline (Azilect), selegiline (Eldepryl, Zelapar), tranylcypromine (Parnate), phenelzine (Nardil), kunye nezinye.

Amayeza acothisa ukujiya kwegazi (iAnticoagulant / iziyobisi zeAntiplatelet)

I-mate ye-Yerba iqulethe icaffeine. I-caffeine inokunciphisa ukucinywa kwegazi. Ukuthatha iqabane lakho kunye namayeza acothisa ukucola kunokunyusa amathuba okugruzuka nokopha.

Amanye amayeza acothisa ukucoca igazi aquka iasprini, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, abanye), ibuprofen (Advil, Motrin, abanye), naproxen (Anaprox, Naprosyn, abanye), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), kunye nezinye.

Inikotini

Iziyobisi ezikhuthazayo ezifana nenicotine ikhawulezisa inkqubo yeemvakalelo. Ngokukhawulezisa inkqubo ye-nervous, amayeza akhuthazayo anokukwenza uzive ujittery kwaye wandise ukubetha kwentliziyo yakho. I-caffeine kwi-yerba iqabane nayo inokukhawulezisa inkqubo ye-nervous. Ukuthatha iqabane lakho kunye neziyobisi ezikhuthazayo kunokubangela iingxaki ezinje ngokunyuka kwenqanaba lentliziyo kunye noxinzelelo lwegazi. Kunqande ukuthatha iziyobisi ezikhuthazayo kunye ne-yerba mate.

IPentobarbital (iNembutal)

Iziphumo ezikhuthazayo zecaffeine kwi-yerba iqabane inokuthintela ukuvelisa iziphumo zokulala kwepentobarbital.

IPhenobarbital (iLuminal)

I-Phenobarbital sisiyobisi esisetyenziselwa ukunyanga ukuxhuzula. I-caffeine kwi-yerba iqabane inokunciphisa iziphumo ze-phenobarbital kwaye inyuse umngcipheko wokubanjwa kwabanye abantu.

IPhenylpropanolamine

I-mate ye-Yerba iqulethe icaffeine. I-caffeine inokuvuselela umzimba. I-Phenylpropanolamine inokuvuselela umzimba. Ukuthatha iqabane kunye ne-phenylpropanolamine kunye kunokubangela ukonyusa kakhulu kunye nokunyusa ukubetha kwentliziyo kunye noxinzelelo lwegazi kwaye kubangele uloyiko.

IPhenytoin (iDilantin)

IPhenytoin sisiyobisi esisetyenziselwa ukunyanga ukuxhuzula. I-caffeine kwi-yerba mate inokunciphisa iziphumo ze-phenytoin. Ukuthatha iqabane lakho nge-phenytoin kunokunciphisa iziphumo ze-phenytoin kunye nokunyusa umngcipheko wokubanjwa kwabanye abantu.

Riluzole (Rilutek)

Umzimba uqhekeza i-riluzole (iRilutek) ukuyikhupha. Ukuthatha iqabane lakho kunokunciphisa ukukhawuleza komzimba ukuphula i-riluzole (Rilutek) kunye nokunyusa iziphumo kunye neziphumo ebezingalunganga ze-riluzole.

Amayeza okuthambisa (i-Benzodiazepines)

I-Benzodiazepines sisiyobisi esibangela ukulala nokozela. Umzimba wophula i-benzodiazepines ukuze uzisuse. I-caffeine kwi-yerba mate inokunciphisa ukonakala kwe-benzodiazepines. Oku kunokunyusa iziphumo ze-benzodiazepines kwaye kubangele ukulala kakhulu. Sukusebenzisa iqabane iqabane ukuba uthatha i-benzodiazepines.

Ezinye i-benzodiazepines zibandakanya i-alprazolam (Xanax), i-clonazepam (i-Klonopin), i-diazepam (i-Valium), i-lorazepam (i-Ativan) kunye nabanye.

Iziyobisi ezikhuthazayo

Iziyobisi ezikhuthazayo zikhawulezisa inkqubo yeemvakalelo. Ngokukhawulezisa inkqubo ye-nervous, amayeza avuselelayo anokukwenza uzive ujitter kwaye ukhawulezise ukubetha kwentliziyo yakho. I-caffeine kwi-yerba mate nayo inokukhawulezisa inkqubo ye-nervous. Ukusetyenziswa kwe-yerba iqabane kunye neziyobisi ezikhuthazayo kunokubangela iingxaki ezinzulu kubandakanya ukonyuka kwentliziyo kunye noxinzelelo lwegazi. Kunqande ukuthatha iziyobisi ezikhuthazayo kunye ne-yerba mate.

Ezinye iziyobisi ezikhuthazayo zibandakanya i-diethylpropion (Tenuate), epinephrine, nicotine, cocaine, amphetamines, phentermine (Ionamin), pseudoephedrine (Sudafed), kunye nezinye ezininzi.

Ithiophylline

I-mate ye-Yerba iqulethe icaffeine. I-caffeine isebenza ngokufanayo kwi-theophylline. I-caffeine inokunciphisa ngokukhawuleza ukuba umzimba ulahla njani i-theophylline. Ukuthatha iqabane lakho kunye ne-theophylline kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga.

IValproate

IValproate sisiyobisi esisetyenziselwa ukunyanga ukuxhuzula. I-caffeine kwi-yerba mate inokunciphisa iziphumo ze-valproate kwaye inyuse umngcipheko wokubanjwa kwabanye abantu.

Verapamil (Calan, abanye)

Umzimba uyayaphula icaffeine kwi-yerba mate ukuze uyilahle. I-Verapamil (Calan, abanye) inokunciphisa ukuba umzimba ulahla njani ngokukhawuleza icaffeine. Ukusela i-yerba iqabane kunye nokuthatha i-verapamil (Calan, abanye) kunokunyusa umngcipheko weziphumo ebezingalindelekanga kubandakanya i-jitteriness, intloko ebuhlungu kunye nokubetha kwentliziyo.

Iipilisi zamanzi (iziyobisi zeDiuretic)

I-caffeine inokunciphisa amanqanaba e-potassium. Iipilisi zamanzi zinokunciphisa amanqanaba e-potassium. Ukuthatha iqabane lakho kunye neepilisi zamanzi kunokunyusa umngcipheko wokunciphisa i-potassium kakhulu.

Ezinye "iipilisi zamanzi" ezinokuphelisa i-potassium zibandakanya i-chlorothiazide (Diuril), chlorthalidone (Thalitone), furosemide (Lasix), hydrochlorothiazide (HCTZ, HydroDiuril, Microzide), nezinye.

Incinci

Jonga olu dibaniso.

Utywala (i-Ethanol)

Umzimba uyayaphula icaffeine kwi-yerba mate ukuze uyilahle. Utywala bunokunciphisa ukuba umzimba uphula ngokukhawuleza njani ikhafeyini. Ukuthatha iqabane lakho kunye notywala kunokubangela i-caffeine eninzi kwigazi kunye neziphumo ebezingalindelekanga kubandakanya ukothuka, intloko ebuhlungu kunye nentliziyo ebetha ngamandla.

Iipilisi zolawulo lokuzalwa (iziyobisi zokuthintela ukukhulelwa)

Umzimba uyayaphula icaffeine kwi-yerba mate ukuze uyilahle. Iipilisi zolawulo lokuzalwa zinganciphisa ukuba umzimba uphula kanjani ngokukhawuleza icaffeine. Ukuthatha iqabane lakho kunye neepilisi zokulawula ukuzalwa kunokubangela ukonwaba, intloko ebuhlungu, ukubetha kwentliziyo okukhawulezileyo, kunye nezinye iziphumo ebezingalindelekanga.

Ezinye iipilisi zolawulo lokuzalwa zibandakanya i-ethinyl estradiol kunye ne-levonorgestrel (Triphasil), i-ethinyl estradiol kunye ne-norethindrone (i-Ortho-Novum 1/35, i-Ortho-Novum 7/7/7), kunye nezinye.

IFluconazole (iDiflucan)

I-mate ye-Yerba iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. IFluconazole (Diflucan) inokunciphisa ukuba umzimba uyilahla ngokukhawuleza kangakanani icaffeine. Oku kunokubangela ukuba icaffeine ihlale ixesha elide emzimbeni kwaye yonyuse umngcipheko weziphumo ebezingalindelekanga ezinje ngokuba novalo, unxunguphalo kunye nokuqaqanjelwa bubuthongo.

Amayeza eswekile (iziyobisi zeAntidiabetes)

Amayeza eswekile asetyenziselwa ukunciphisa iswekile yegazi. I-mate ye-Yerba iqulethe icaffeine. Iingxelo zibanga ukuba icaffeine inokunyusa okanye inciphise iswekile egazini. Iqabane le-Yerba linokuphazamisa ukulawulwa kweswekile yegazi kunye nokunciphisa ukusebenza kwamayeza eswekile. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo weyeza lakho leswekile unokufuna ukuba utshintshwe.

Amanye amayeza asetyenziselwa isifo seswekile aquka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbutamide (i-Orinase), .

Amayeza anciphisa ukwahlulwa kwamanye amayeza sisibindi (ICytochrome P450 CYP1A2 (CYP1A2) inhibitors)

I-mate ye-Yerba iqulethe icaffeine. I-caffeine yonakele sisibindi. Amanye amayeza anciphisa indlela isibindi esiwaphula ngayo amanye amayeza. La mayeza atshintsha isibindi anokunciphisa ukuba ikhafeyini ekhawulezayo kwi-yerba mate yaphulwe njani emzimbeni. Oku kunokunyusa iziphumo kunye neempembelelo zecaffeine kwi-yerba mate. Amanye amayeza atshintsha isibindi abandakanya i-cimetidine (Tagamet), i-fluvoxamine, i-mexiletine, i-clozapine, i-theophylline, kunye nezinye.

IMetformin (iGlucophage)

I-mate ye-Yerba iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. IMetformin (iGlucophage) inokunciphisa ukuba umzimba uphula kanjani ngokukhawuleza icaffeine. Ukuthatha iqabane iqabane kunye ne-metformin kunokubangela i-caffeine eninzi emzimbeni, kwaye yonyuse iziphumo kunye neziphumo ze-caffeine.

IMethoxsalen (iOxsoralen)

I-mate ye-Yerba iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. IMethoxsalen (iOxsoralen) inokunciphisa ngokukhawuleza ukuba umzimba uyaphula icaffeine. Ukuthatha i-caffeine kunye ne-methoxsalen kunokubangela i-caffeine eninzi emzimbeni, kwaye kwandise iziphumo kunye neempembelelo zecaffeine.

Mexiletine (Mexitil)

I-mate ye-Yerba iqulethe icaffeine. Umzimba uyayaphula icaffeine ukuze uyilahle. I-Mexiletine (Mexitil) inokunciphisa ngokukhawuleza ukuba umzimba uyaphula njani icaffeine. Ukuthatha i-Mexiletine (Mexitil) kunye ne-yerba mate kunokunyusa iziphumo ze-caffeine kunye neziphumo ebezingalindelekanga ze-yerba mate.

I-Terbinafine (iLamisil)

Umzimba wophula i-caffeine (equlethwe kwi-yerba mate) ukuze uyilahle. I-Terbinafine (i-Lamisil) inganciphisa ukuba umzimba ulahla njani ikhafeyini ngokukhawuleza kwaye inyuse umngcipheko weziphumo ebezingalindelekanga kubandakanya ukothuka, intloko ebuhlungu, ukubetha kwentliziyo kunye nezinye iziphumo.

ITiagabine (eGabitril)

I-mate ye-Yerba iqulethe icaffeine. Ukuthatha i-caffeine ngaphezulu kwexesha kunye ne-tiagabine kunokunyusa inani le-tiagabine emzimbeni. Oku kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga ze-tiagabine.

ITiclopidine (iTiclid)

Umzimba uyayaphula icaffeine kwi-yerba mate ukuze uyilahle. I-Ticlopidine (Ticlid) inokunciphisa ukuba umzimba ulahla njani ngokukhawuleza icaffeine. Ukuthatha iqabane iqabane kunye ne-ticlopidine kunokunyusa iziphumo kunye neziphumo zecaffeine, kubandakanya ukomelela, ukungakhathali, ukuba nochuku, kunye nabanye

Ikrakra iorenji

Sukusebenzisa i-yerba iqabane ngeorenji ezikrakra. Umdibaniso unokuwongamela umzimba, ukhokelele ekunyukeni koxinzelelo lwegazi kunye nokubetha kwentliziyo, nakubantu abanoxinzelelo lwegazi oluqhelekileyo.

Imifuno eneCaffeine kunye nezongezo

I-mate ye-Yerba iqulethe icaffeine. Ukuyisebenzisa kunye namanye amayeza okanye izongezo eziqukethe i-caffeine inokunyusa umngcipheko weziphumo ezinxulumene ne-caffeine. Ezinye iimveliso zendalo eziqukethe i-caffeine zibandakanya i-cocoa, ikofu, icola nut, iti emnyama, iti ye-oolong kunye ne-guarana.

Ikhalsiyam

I-caffeine kwi-yerba mate ithambekele ekwandiseni ukususwa komzimba we-calcium. Ukuba usebenzisa iqabane elininzi, cela umboneleli wakho wezempilo ukuba kufuneka uthathe i-calcium eyongezelelweyo ukunceda ukwenza i-calcium elahlekileyo kumchamo.

Yila

Kukho inkxalabo yokuba ukudibanisa i-caffeine, ikhemikhali efumaneka kwi-yerba mate, kunye ne-ephedra kunye ne-creatine kunokunyusa umngcipheko weziphumo ezinobungozi. Imbaleki enye ethathe iigrama ezi-6 zokudala i-monohydrate, i-400-600 mg ye-caffeine, i-40-60 mg ye-ephedra, kunye nezinye izongezo zemihla ngemihla kangangeeveki ezi-6. I-Caffeine isenokunciphisa amandla e-creatine okuphucula ukusebenza kweembaleki.

Ephedra (Ma huang)

Sukusebenzisa i-yerba mate nge-ephedra. Olu dibana lunokuwugqithisa umzimba kwaye lonyuse umngcipheko wokubeka emngciphekweni ubomi okanye iimeko ezikhubazayo, ezinje ngoxinzelelo oluphezulu lwegazi, isifo sentliziyo, ukubetha, nokuhlutha. Le ndibaniselwano inokubangela nokufa.

Iherbs kunye nezongezo ezicothisa igazi

Iqabane le-Yerba linokucothisa ukujiya kwegazi. Ukuyisebenzisa kunye namanye amayeza okanye izongezo ezinesiphumo esifanayo kunokunyusa umngcipheko wokugruzuka nokopha kwabanye abantu. Amanye ala mayeza abandakanya i-angelica, i-clove, i-danshen, igalikhi, ijinja, iginkgo, iPanax ginseng, kunye nezinye.

Magnesium

I-mate ye-Yerba iqulethe icaffeine. I-caffeine kwi-yerba iqabane inokunyusa ukuba ingakanani i-magnesium ekhutshwayo kumchamo.

Akukho kunxibelelana kwaziwayo nokutya.

Idosi efanelekileyo yeqabane ixhomekeke kwizinto ezininzi ezinje ngeminyaka yomsebenzisi, impilo, kunye nezinye iimeko. Ngeli xesha akukho lwazi lwaneleyo lwesayensi ukumisela uluhlu olufanelekileyo lweedosi zeqabane. Gcina ukhumbula ukuba iimveliso zendalo azisoloko zikhuselekile kwaye iidosi zibalulekile. Qiniseka ukuba ulandela umkhombandlela ofanelekileyo kwiilebheli zemveliso kwaye uqhagamshelane nosokhemesti okanye ugqirha okanye olunye uqeqesho kwezempilo ngaphambi kokusebenzisa.

Chimarrao, Green Mate, Hervea, Ilex, Ilex paraguariensis, Tea yaseBritani yamaJesuit, Iti yamaJesuit, Maté, Maté Folium, IParaguay Tea, Iti yaseSt. , Yerba Mate, Yerba Maté.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. UGómez-Juaristi M, uMartínez-López S, uSarria B, uBravo L, uMateos R.Ukufunxwa kunye nokusetwa kwemichiza ye-yerba mate phenolic compounds ebantwini. Ukutya Chem. Ngo-2018; 240: 1028-1038. Jonga i-abstract.
2. UChaves G, uBritez N, uOviedo G, et al. Iziselo ezinxilisayo ze-Ilex paraguariensis iziselo zibonisa iiprofayili ezisezantsi zeepid kodwa ubunzima bomzimba buphezulu. Phytother Res. 2018; 32: 1030-1038. Jonga i-abstract.
3. Wikoff D, Welsh BT, Henderson R, et al. Ukuphononongwa ngokuchanekileyo kweziphumo ezinokubakho zokusetyenziswa kwe-caffeine kubantu abadala abasempilweni, abasetyhini abakhulelweyo, abakwishumi elivisayo kunye nabantwana. Ukutya iChem Toxicol 2017; 109: 585-648. Jonga i-abstract.
4. IVoskoboinik A, uKalman JM, uKistler PM. Caffeine kunye ne-arrhythmias: ixesha lokusila idatha. I-JACC: Iklinikhi ye-Electrophysiol. 2018; 4: 425-32.
5. ILagier D, Nee L, Guieu R, et al. I-Peri-operative yomlomo we-caffeine ayithinteli i-postoperative atrial fibrillation emva kokuhlinzwa kwentliziyo ye-valve kunye ne-cardiopulmonary bypass: ityala elilawulwa ngokungahleliwe. I-Eur J iAnaesthesiol. 2018 Epreli 26. [Epub ngaphambi koshicilelo] Jonga okungafakwanga.
6. USouza SJ, uPetrilli AA, uTeixeira AM, et al. Iziphumo zetshokholethi kunye neti yeqabane kwiprofayili ye-lipid yabantu abane-HIV / AIDS kunyango lwe-antiretroviral: ulingo lwezonyango. Isondlo. Ngo-2017 uNov-Dec; 43-44: 61-68. Jonga i-abstract.
7. I-Areta JL, iAustarheim I, iWangensteen H, uCapelli C.Imetabolic kunye nokusebenza kweziphumo ze-yerba iqabane kwiibhayisikile eziqeqeshwe kakuhle. Ukuzivocavoca kweMed Sci. Ngo-2017 uNov 7. Jonga i-abstract.
8. UJung JH, uHur Y-I. Iziphumo zokukhutshwa kweqabane kubunzima bomzimba kunye nokuncitshiswa kwamafutha kubafazi abatyebe kakhulu: uvavanyo lweklinikhi olulawulwa ngokungenamkhethe. I-Korea J OBes. Ngo-2016; 25: 197-206.
9. I-Alkhatib A, i-Atcheson R. Yerba Mate (Ilex paraguariensis) ye-metabolic, satiety, kunye neemeko zempembelelo kwimeko yokuphumla kunye nexesha lokuzilolonga ixesha elide. Izondlo. Ngo-2017 Agasti 15; 9. IPii: E882. Jonga i-abstract.
10. I-veiga DTA, i-Bringhenti R, iBolignon AA, et al. Ukuthatha iqabane kwi-yerba kunefuthe lokungathathi hlangothi kwithambo: isifundo solawulo lwamatyala kubafazi abasele besemini. Phytother Res. NgoJanuwari 2018; 32: 58-64. Jonga i-abstract.
11. UZuchinali P, Riberio PA, Pimentel M, da Rosa PR, Zimerman LI, Rohde LE. Iziphumo zecaffeine kwi-ventricular arrhythmia: uphononongo lwenkqubo kunye nohlalutyo lweemeta zovavanyo kunye nonyango lwezifundo. I-Europace 2016 ngoFebruwari; 18: 257-66. Jonga i-abstract.
12. I-Arhente yeHlabathi yoPhando ngomhlaza (IARC). I-IARC monographs ivavanya ikofu yokusela, iqabane, kunye neziselo ezishushu kakhulu. https://www.iarc.fr/en/media-centre/pr/2016/pdfs/pr244_E.pdf. Kufumaneka ngoNovemba 1, 2017.
13. UKim SY, Owu MR, Kim MG, Chae HJ, Chae SW. Iziphumo zokulwa nokutyeba kakhulu kwe-yerba mate (Ilex Paraguariensis): uvavanyo lweklinikhi olulawulwa ngokungahleliwe, oluyimfama kabini. I-BMC yokuGqibezela enye iMed. Ngo-2015; 15: 338. Jonga i-abstract.
14. Yu S, Yue SW, Liu Z, Zhang T, Xiang N, Fu H. Yerba iqabane (Ilex paraguariensis) liphucula i-microcirculation yamavolontiya ane-viscosity ephezulu yegazi: ityala elilawulwa ngokungahleliwe, elingaboniyo nelilawulwa yi-placebo. Exp Gerontol. 2015; 62: 14-22. Jonga i-abstract.
15. UStefani ED, Moore M, uAune D, uDeneo-Pellegrini H, uRonco AL, uBoffetta P, et al. Ukusetyenziswa kweMat kunye nomngcipheko womhlaza: isifundo esilawula indawo ezininzi e-Uruguay. I-Asia Pac J Umhlaza ngaphambili. Ngo-2011; 12: 1089-93. Jonga i-abstract.
16. IGambero A kunye neRibeiro ML. Iziphumo ezilungileyo ze-yerba mate (Ilex paraguariensis) ekutyebeni kakhulu. Izondlo. Ngo-2015; 7: 730-50. Jonga i-abstract.
17. UDixit S, Stein PK, Dewland TA, Dukes JW, Vittinghoff E, Heckbert SR, kunye noMarcus GM. Ukusetyenziswa kweeMveliso zeCaffeine kunye neCardiac Ectopy. J Ndiyintliziyo ye-Assoc. Ngo-2016 26; 5. pii: e002503. ikhonkco: 10.1161 / JAHA.115.002503. Jonga i-abstract.
18. U-Cheng M, u-Hu Z, u-X u-u-Huang J, u-Gu D. I-Caffeine yokungenisa kunye ne-atrial fibrillation yezehlo: impendulo yedosi meta-uhlalutyo lwezifundo ezinokubakho zeqela. Ngaba uJ Cardiol. Ngo-2014 ngoMatshi; 30: 448-54. ikhonkco: 10.1016 / j.cjca.2013.12.026. Epub 2014 2. Ukuphononongwa. Jonga i-abstract.
19. UCaldeira D, uMartins C, u-Alves LB, uPereira H, uFerreira JJ, uCosta J. I-Caffeine ayonyusi umngcipheko we-atrial fibrillation: uphononongo olucwangcisiweyo kunye nohlalutyo lwe-meta. Intliziyo. Ngo-2013; 99: 1383-9. ikhonkco: 10.1136 / heartjnl-2013-303950. Uphononongo. Jonga i-abstract.
20. UMeyer, K. kunye neBhola, P. Iziphumo zengqondo kunye neentliziyo kunye nemiphumo yeGuarana kunye neYerba Mate: Ukuthelekiswa nekofu. Uhlaziyo lwe-Interamericana de Psicologia 2004; 38: 87-94.
21. UKlein, GA, Stefanuto, A., Boaventura, BC, de Morais, EC, Cavalcante, Lda S., de, Andrade F., Wazlawik, E., Di Pietro, PF, Maraschin, M., kunye da Silva, EL Iti ye-Mate (Ilex paraguariensis) iphucula iiprofayili ze-glycemic kunye ne-lipid yohlobo lwe-2 yeswekile kunye nabantu abanesifo seswekile ngaphambili: isifundo somqhubi wenqwelomoya. J Ndingu-Coll. Ngo-2011; 30: 320-332. Jonga i-abstract.
22. U-Hussein, G. M., Matsuda, H., Nakamura, S., Akiyama, T., Tamura, K., kunye no-Yoshikawa, M. Iziphumo zokukhusela kunye neempawu zokuzonwabisa zomlingane (Ilex paraguariensis) kwisifo se-metabolic syndrome kwiimpuku ze-TSOD. Unyango lwezonyango. 12-15-2011; 19: 88-97. Jonga i-abstract.
23. de Morais, EC, Stefanuto, A., Klein, GA, Boaventura, BC, de, Andrade F., Wazlawik, E., Di Pietro, PF, Maraschin, M., no da Silva, EL Ukusetyenziswa kwe-yerba mate (Ilex paraguariensis) iphucula iiparameter ze-serum lipid kwizifundo zedyslipidemic esempilweni kwaye ibonelela ngonciphiso olongezelelekileyo lwe-LDL-cholesterol kubantu abakunyango lwe-statin. J Agric. Ukutya Chem. 9-23-2009; 57: 8316-8324. Jonga i-abstract.
24. UMartins, F., Noso, TM, Porto, VB, Curiel, A., Gambero, A., Bastos, DH, Ribeiro, ML, kunye noCarvalho, Pde O. I-mate tea inqanda in vitro pancreatic lipase ye-lipase kwaye inefuthe le-hypolipidemic ukutya okunamafutha amaninzi kwenza iimpuku ezityebileyo zokutya. Ukutyeba kakhulu. (Isilivere yeSpring) 2010; 18: 42-47. Jonga i-abstract.
25. Arcari, DP, Bartchewsky, W., dos Santos, TW, Oliveira, KA, Funck, A., Pedrazzoli, J., de Souza, MF, Saad, MJ, Bastos, DH, Gambero, A., Carvalho, Pde O ., Kunye noRibeiro, ML Iziphumo ze-antiobesity zokukhupha iqabane (Ilex paraguariensis) kwiimpuku ezityebileyo zokutya okunamafutha. Ukutyeba kakhulu. (Isilivere yeSpring) 2009; 17: 2127-2133. Jonga i-abstract.
26. ISugimoto, S., Nakamura, S., Yamamoto, S., Yamashita, C., Oda, Y., Matsuda, H., kunye neYoshikawa, M. amayeza endalo aseBrazil. III. izakhiwo ze-triterpene oligoglycosides kunye ne-lipase inhibitors ezivela kwiqabane, amagqabi e-ilex paraguariensis. I-Chem.Pharm.Inkunzi yenkomo. (Tokyo) 2009; 57: 257-261. Jonga i-abstract.
27. Matsumoto, RL, Bastos, DH, Mendonca, S., Nunes, VS, Bartchewsky, W., Ribeiro, ML, kunye no-Oliveira, uCarvalho P. I-peroxidation, kunye nenqanaba elipheleleyo le-antioxidant kubafazi abancinci abasempilweni. J Agric. Ukutya Chem. 3-11-2009; 57: 1775-1780. Jonga i-abstract.
28. I-Pang, J., Choi, Y., kunye nePaki, T. Ilex paraguariensis ikhupha ukukhuthaza ukutyeba okubangelwa kukutya okunamafutha aphezulu: indima enokubakho ye-AMPK kwithishu ye-visceral adipose. IArch. Ibhayoloji. 8-15-2008; 476: 178-185. Jonga i-abstract.
29. UMiranda, DD, Arcari, DP, Pedrazzoli, J., Jr., Carvalho, Pde O., Cerutti, SM, Bastos, DH, kunye noRibeiro, ML Iziphumo ezikhuselayo zeti yeqabane (Ilex paraguariensis) kwi-H2O2 eyenzelwe umonakalo weDNA Ukulungiswa kwe-DNA kwiimpuku. IMutagenesis 2008; 23: 261-265. Jonga i-abstract.
30. IMilioli, EM, Cologni, P., Santos, CC, Marcos, TD, Yunes, VM, Fernandes, MS, Schoenfelder, T., kunye neCosta-Campos, L. Iziphumo zolawulo olunamandla lokukhutshwa kwehydroalcohol kwi-Ilex paraguariensis St Hilaire ( Aquifoliaceae) kwiimodeli zezilwanyana zesifo sikaParkinson. Umzimba weRes 2007; 21: 771-776. Jonga i-abstract.
31. UMartin, I., Lopez-Vilchez, M. A., Mur, A., Garcia-Algar, O., Rossi, S., Marchei, E., kunye nePichini, S. Unyango lweziyobisi kwiTher. Ngo-2007; 29: 127-129. Jonga i-abstract.
32. UMosimann, A. L., uWilhelm-Filho, D., kunye no-da Silva, u-E. Biofactors 2006; 26: 59-70. Jonga i-abstract.
33. UGorzalczany, S., Filip, R., Alonso, M. R., Mino, J., Ferraro, G. E., kunye no-Acevedo, C. Impembelelo yeCholeretic kunye nokuhamba kwamathumbu emathunjini 'omlingane' (Ilex paraguariensis) kunye nabatshintshi bayo okanye abakrexezayo. J U-Ethnopharmacol. 2001; 75 (2-3): 291-294. Jonga i-abstract.
34. UFonseca, C. A., Otto, S. S., Paumgartten, F. J., kunye noLeitao, A. C. Inontoxic, mutagenic, kunye nemisebenzi ye-clastogenic ye-Mate-Chimarrao (Ilex paraguariensis). J. Indawo, IPathol, iTyhefu, iOncol. Ngo-2000; 19: 333-346. Jonga i-abstract.
35. UMartinet, A., Hostettmann, K., kunye noSchutz, Y. Iziphumo zeThermogenic yamalungiselelo ezityalo athengiswayo ajolise ekunyangeni ukutyeba kwabantu. Unyango lwezonyango. Ngo-1999; 6: 231-238. Jonga i-abstract.
36. UPittler, M.H, Schmidt, K., no-Ernst, E. Iziganeko ezingalunganga zokutya okunezithako zokunciphisa ubunzima bomzimba: uphononongo lwenkqubo. Isithsaba Ngo-2005; 6: 93-111. Jonga i-abstract.
37. Pittler, M.H kunye no-Ernst, E. Izongezo zokutya zokunciphisa umzimba: uphononongo lwenkqubo. Ndingu. J. Clinic Isondlo. Ngo-2004; 79: 529-536. Jonga i-abstract.
38. UDickel, M. L., amaxabiso, S. M., kunye noRitter, M. R. Izityalo zidla ngokusetyenziselwa ukukhulula ubunzima ePorto Alegre, eMzantsi Brazil. J U-Ethnopharmacol 1-3-2007; 109: 60-71. Jonga i-abstract.
39. UFotherby, M. D., Ghandi, C., Haigh, R. A., Macdonald, T. A., kunye noPotter, uJ. I-Cardiology kwi-1994 yabantu abadala; 2: 499-503.
40. UJeppesen, U., Loft, S., Poulsen, H., kunye noBrsen, K. Isifundo sokudibana kwe-fluvoxamine-caffeine. I-Pharmacogenetics 1996; 6: 213-222. Jonga i-abstract.
41. I-Smits, P., ababolekisi, uJ. W., kunye no-Thien, T. Caffeine kunye ne-theophylline attenuate adenosine-indased vasodilation ebantwini. Kwiklinikhi yeParmacol. Ngo-1990; 48: 410-418. Jonga i-abstract.
42. IGronroos, N. N. kunye noAlonso, A. Ukutya kunye nomngcipheko we-atrial fibrillation-epidemiologic kunye nobungqina beklinikhi-. Isangqa. J 2010; 74: 2029-2038. Jonga i-abstract.
43. UClausen, T. IHormonal kunye nohlengahlengiso lwe-pharmacological yeplasma potassium homeostasis. IClin Pharmacol 2010; 24: 595-605. Jonga i-abstract.
44. Reis, J. P., Loria, C. M., Steffen, L. M., Zhou, X., van, Uphondo L., Siscovick, D. S., Jacobs, D.R., Jr., kunye noCarr, uJ. J. Coffee, ikofu engenamanzi, icaffeine, kunye nokusela iti ebudaleni kunye nakwi-atherosclerosis kamva ebomini: isifundo seCARDIA. IArterioscler iTromb. IVasc. IBiol 2010; 30: 2059-2066. Jonga i-abstract.
45. I-Bracesco, N., Sanchez, A. G., Contreras, V., Menini, T., kunye neGugliucci, A. Inkqubela phambili yakutshanje kuphando lwe-Ilex paraguariensis: Minireview. J U-Ethnopharmacol. 6-26-2010; Jonga i-abstract.
46. I-Conen, D., i-Chiuve, i-E, i-Everett, i-B., I-Zhang, i-S, i-M, i-Buring, i-E, kunye ne-Albert, i-C. M. Caffeine ukusetyenziswa kunye ne-atrial fibrillation yabasetyhini. NdinguJ J weeKlinikhi ngo-2010; 92: 509-514. Jonga i-abstract.
47. U-Ernest, D., Chia, M., kunye no-Corallo, C. E. I-hypokalaemia enzulu ngenxa yokusetyenziswa gwenxa kwe-Nurofen Plus kunye ne-Red Bull. Ukuhlaziywa kweCrit Care Resusc. Ngo-2010; 12: 109-110. Jonga i-abstract.
48. Rigato, I., Blarasin, L., kunye noKette, F.Ihypokalemia enzima kubagibeli beebhayisekile abancinci aba-2 ngenxa yokutya kakhulu ikhaffeine. Iiklinikhi J zeMidlalo. Ngo-2010; 20: 128-130. Jonga i-abstract.
49. I-Simmonds, M.J, Minahan, C.L, kunye neSabapathy, S. Caffeine iphucula ibhayisekile ephezulu kodwa hayi inqanaba lokukhululwa kwamandla kwe-anaerobic. I-Eur. J Appl yePhysol 2010; 109: 287-295. Jonga i-abstract.
50. UZhang, W., Lopez-Garcia, E., Li, T. Y., Hu, F. B., kunye ne-van Dam, R. M. Ukusetyenziswa kwekhofi kunye nomngcipheko wezifo zentliziyo kunye nazo zonke izizathu ezibangela ukusweleka phakathi kwamadoda ane-2 yeswekile. Unonophelo lweSwekile 2009; 32: 1043-1045. Jonga i-abstract.
51. I-Lopez-Garcia, E., Rodriguez-Artalejo, F., Rexrode, K. M., Logroscino, G., Hu, F. B., kunye ne-van Dam, R. M. Ukusetyenziswa kwekhofi kunye nomngcipheko wokubetha kwabasetyhini. Ukujikeleza kwe-3-3-2009; 119: 1116-1123. Jonga i-abstract.
52. I-Smits, P., Temme, L., kunye no-Thien, T.Ukuhlangana kwentliziyo phakathi kwe-caffeine kunye ne-nicotine ebantwini. KwiKlinikhi ye-Pharmacol Ther 1993; 54: 194-204. Jonga i-abstract.
53. ROTH, J. L. Uvavanyo lwezonyango lwe-caffeine uhlalutyo lwesisu kwizigulana ezinesilonda esiswini. I-Gastroenterology 1951; 19: 199-215. Jonga i-abstract.
54. UJoeres R, uRichter E. Mexiletine kunye nokupheliswa kwe-caffeine. N Engl J Med 1987; 317: 117. Jonga i-abstract.
55. UZelenitsky SA, uNorman A, uNix DE. Iziphumo zefluconazole kwi-pharmacokinetics ye-caffeine kwizifundo ezincinci nezindala. J Ukuchaphazela i-Dis Pharmacother 1995; 1: 1-11.
56. UMatila MJ, uVainio P, uNurminen ML, et al. I-Midazolam 12 mg ichasene ngokulinganayo yi-250 mg caffeine emntwini. I-Int J Clin Pharmacol Ther 2000; 38: 581-7. Jonga i-abstract.
57. UMatila ME, uMatila MJ, uNuotto E. I-Caffeine ngokuphakathi ichasene nefuthe le-triazolam kunye ne-zopiclone ekusebenzeni kwengqondo kwizifundo ezisempilweni. IPhemacol Toxicol 1992; 70: 286-9. Jonga i-abstract.
58. UMatila MJ, uNuotto E. Caffeine kunye ne-theophylline counteract diazepam kwi-man. I-Med Biol 1983; 61: 337-43. Jonga i-abstract.
59. UMatila MJ, uPalva E, uSavolainen K. Caffeine ichasene nefuthe le-diazepam emntwini. I-Med Biol 1982; 60: 121-3. Jonga i-abstract.
60. Ifayile SE, iBond AJ, uLister RG. Unxibelelwano phakathi kweziphumo zecaffeine kunye ne-lorazepam kwiimvavanyo zentsebenzo kunye nokuzikala. J Iklinikhi yePsychopharmacol 1982; 2: 102-6. Jonga i-abstract.
61. UBroughton LJ, uRogers HJ. Ukucutha ukucocwa kwecaffeine ngenxa yecimetidine. UBr J Clin Pharmacol 1981; 12: 155-9. Jonga i-abstract.
62. UAzcona O, uBarbanoi MJ, uTorrent J, uJane F.Uvavanyo lweziphumo eziphambili zotywala kunye nokusebenzisana kwe-caffeine. UBr J Clin Pharmacol 1995; 40: 393-400. Jonga i-abstract.
63. UNorager, C. B., Jensen, M. B., Weimann, A., kunye noMadsen, M. R. Iziphumo zeMetabolic zokungenisa i-caffeine kunye nokusebenza komzimba kubemi abaneminyaka engama-75 ubudala. Isifundo esingahleliwe, esingaboniyo, esilawulwa yi-placebo, esifundweni esingaphaya kokufunda. Iiklinikhi ze-Endocrinol (Oxf) 2006; 65: 223-228. Jonga i-abstract.
64. Mays, D., Camisa, C., Cheney, P., Pacula, C. M., Nawoot, S., kunye noGerber, N. Methoxsalen sisithintelo esinamandla semetabolism ye-caffeine ebantwini. Kwiklinikhi yeParmacol. Ngowe-1987; 42: 621-626. Jonga i-abstract.
65. Mohiuddin, M., Azam, A. T., Amran, M. S., kunye noHossain, M. A. Kwiziphumo ezibonakalayo ze-gliclazide kunye ne-metformin kwi-plasma ye-caffeine kwiigundane ezisempilweni. Pak. J Biol Sci 5-1-2009; 12: 734-737 (PubMed) (Umnqamlezo) Jonga i-abstract.
66. Gasior, M., Swiader, M., Przybylko, M., Borowicz, K., Turski, WA, Kleinrok, Z., kunye noCzuczwar, SJ Felbamate ibonisa ukuthambeka okuphantsi kokunxibelelana ne-methylxanthines kunye ne-Ca2 + iimodyuli zesiteshi ngokuchasene nokuvavanywa kovavanyo kwiimpuku. . I-Eur. J Pharmacol 7-10-1998; 352 (2-3): 207-214. Jonga i-abstract.
67. UVaz, J., Kulkarni, C., David, J., noJoseph, T. Impembelelo ye-caffeine kwiprofayili ye-pharmacokinetic ye-sodium valproate kunye ne-carbamazepine kumavolontiya aqhelekileyo abantu. Indiya J.Exp. Ibhayol. Ngo-1998; 36: 112-114. Jonga i-abstract.
68. IChroscinska-Krawczyk, M., Jargiello-Baszak, M., Walek, M., Tylus, B., kunye noCzuczwar, S. J. Caffeine kunye namandla e-anticonvulsant amachiza e-antiepileptic: idatha yovavanyo kunye neklinikhi. IPhemacol. Ngo-2011; 63: 12-18. Jonga i-abstract.
69. ILuszczki, J., Zuchora, M., Sawicka, K. M., Kozinska, J., kunye noCzuczwar, S. J. Ukuvezwa ngokukuko kwi-caffeine kunciphisa isenzo se-anticonvulsant se-ethosuximide, kodwa hayi eyokuxhamla kwe-clonazepam, phenobarbital kunye ne-valproate ngokuchasene ne-pentetrazole-induction seiz. IPhemacol Rep. 2006; 58: 652-659. Jonga i-abstract.
70. UJankiewicz, K., Chroscinska-Krawczyk, M., Blaszczyk, B., kunye noCzuczwar, S. J. [Caffeine kunye neziyobisi ezichasene ne-antiepileptic: idatha yovavanyo kunye neklinikhi]. Przegl.Ilek. Ngo-2007; 64: 965-967. Jonga i-abstract.
71. UGasior, M., Borowicz, K., Buszewicz, G., Kleinrok, Z., kunye noCzuczwar, S. J. Umsebenzi weAnticonvulsant we-phenobarbital kunye ne-valproate ngokuchasene ne-electroshock ephezulu kwiimpuku ngexesha lonyango olungapheliyo kunye ne-caffeine kunye ne-caffeine yokuyeka. Isifo sokuwa 1996; 37: 262-268. Jonga i-abstract.
72. UKot, M. noDaniel, W. A. ​​Iziphumo ze-diethyldithiocarbamate (DDC) kunye ne-ticlopidine kwimisebenzi ye-CYP1A2 kunye ne-caffeine metabolism: isifundo se-vitro sokuthelekisa kunye ne-cDNA yomntu-echazwe i-CYP1A2 kunye ne-microsomes yesibindi. IPhemacol Rep. 2009; 61: 1216-1220. Jonga i-abstract.
73. UFuhr, U., Strobl, G., Manaut, F., Anders, EM, Sorgel, F., Lopez-de-Brinas, E., Chu, DT, Pernet, AG, Mahr, G., Sanz, F. , kunye. I-Quinolone antibacterial agents: ubudlelwane phakathi kolwakhiwo kunye ne-in vitro inhibition yecytochrome yomntu P450 isoform CYP1A2. Umol. IPharmacol. Ngo-1993; 43: 191-199. Jonga i-abstract.
74. I-Stille, W., Harder, S., Mieke, S., Beer, C., Shah, P. M., Frech, K., kunye neStaib, A. H. Ukuncitshiswa kokupheliswa kwe-caffeine emntwini ngexesha lokulawulwa kwe-4-quinolones. J. Izixhobo zokulwa. Ngo-1987; 20: 729-734. Jonga i-abstract.
75. Staib, A.H, Stille, W., Dietlein, G., Shah, P.M, Harder, S., Mieke, S., kunye neBeer, C.Ukusebenzisana phakathi kwequinolones kunye necaffeine. Iziyobisi 1987; 34 Suppl 1: 170-174. Jonga i-abstract.
76. Shet, M. S., McPhaul, M., Fisher, C. W., Stallings, N. R., kunye no-Estabrook, R. W. Metabolism weziyobisi ze-antiandrogenic (Flutamide) yi-CYP1A2 yabantu. Ukuchithwa kweMetab yeziyobisi. Ngo-1997; 25: 1298-1303. Jonga i-abstract.
77. IKynast-Gales SA, iMassey LK. Iziphumo zecaffeine kwi-circadian excretion ye-urinary calcium kunye ne-magnesium. J NdinguColl Nutraki. Ngo-1994; 13: 467-72. Jonga i-abstract.
78. UOchiai R, uJokura H, uSuzuki A, et al. Ukukhutshelwa kwembotyi yekofu eluhlaza kuphucula ukungasebenzi kakuhle komntu. IiHypertens Res 2004; 27: 731-7. Jonga i-abstract.
79. IConforti AS, uGallo ME, uSaraví FD. Ukusetyenziswa kwe-Yerba Mate (Ilex paraguariensis) kunxulunyaniswa nokuxinana kwamaminerali aphezulu kumabhinqa asemva kokuyeka ukuya exesheni. Amathambo 2012; 50: 9-13. Jonga i-abstract.
80. URobinson LE, uSavani S, uBattram DS, et al. Ukungenisa i-caffeine ngaphambi kovavanyo lokunyamezelwa kweswekile yomlomo kuphazamisa ulawulo lweglucose yegazi kumadoda ane-2 yeswekile. J Amanqatha 2004; 134: 2528-33. Jonga i-abstract.
81. ILake CR, iRosenberg DB, iGallant S, et al. I-Phenylpropanolamine inyusa amanqanaba e-plasma caffeine. KwiKlinikhi ye-Pharmacol Ther 1990; 47: 675-85. Jonga i-abstract.
82. I-Forrest WH Jr, iBellville JW, uBrown BW Jr.Ukusebenzisana kwe-caffeine kunye ne-pentobarbital njenge-hypnotic yasebusuku. I-Anesthesiology 1972; 36: 37-41. Jonga i-abstract.
83. URaaska K, uRaitasuo V, uLaitila J, uNeuvonen PJ. Iziphumo zecaffeine equlathe ikofu enganyibilikiweyo kwindawo ekugxininiswe kuyo i-serum clozapine kwizigulana ezibhedlele. Isiseko seKlinikhi yePhemacol Toxicol 2004; 94: 13-8. Jonga i-abstract.
84. UWatson JM, uSherwin RS, uDeary IJ, et al. Ukwahlulahlulahlulwa komzimba okwandisiweyo, iimpendulo zehomoni kunye nokuqonda kwi-hypoglycaemia ngokusetyenziswa kwecaffeine okuzinzileyo. Iiklinikhi yeSci (uLond) 2003; 104: 447-54. Jonga i-abstract.
85. IWinkelmayer WC, iStampfer MJ, iWillett WC, iCurhan GC. Ukutya okuqhelekileyo kwe-caffeine kunye nomngcipheko wexinzelelo lwexinzelelo kubafazi. IJAMA 2005; 294: 2330-5. Jonga i-abstract.
86. UJuliano LM, noGriffiths RR. Uphengululo olubalulekileyo lokurhoxiswa kwecaffeine: ubungqina bokuqina kweempawu kunye neempawu, izehlo, ubungqongqo, kunye neempawu ezinxulumene noko. Ingqondo yePsychopharmacology (Berl) 2004; 176: 1-29. Jonga i-abstract.
87. I-Leson CL, McGuigan MA, iBryson SM. I-caffeine overdose kwindoda efikisayo. J Ityhefu yeklinikhi yetyhefu 1988; 26: 407-15. Jonga i-abstract.
88. UBenowitz NL, u-Osterloh J, uGoldschlager N, et al. Ukukhutshwa kwe-catecholamine enkulu kwi-caffeine yetyhefu. IJAMA 1982; 248: 1097-8. Jonga i-abstract.
89. UAcheson KJ, uGremaud G, Meirim I, et al. Iziphumo zeMetabolic zecaffeine ebantwini: i-lipid oxidation okanye ibhayisekile engenamsebenzi? NdinguJ J Clin Nutriti 2004; 79: 40-6. Jonga i-abstract.
90. IHallerle CA, uBenowitz NL, uJacob P 3rd. Iziphumo zeHemodynamic ze-ephedra-free-weight loss-supplements ebantwini. NdinguJ Med 2005; 118: 998-1003 .. Jonga i-abstract.
91. ISantos IS, iMatijasevich A, iValle NC. Ukusela amaqabane ngexesha lokukhulelwa kunye nomngcipheko wokuqala kwangaphambi kokuzalwa kunye nokuncinci ekuzalweni kweminyaka yobudala. J Utyando 2005; 135: 1120-3. Jonga i-abstract.
92. UPetrie HJ, uChown SE, uBelfie LM, et al. Ukungenisa kweCaffeine kwandisa impendulo ye-insulin kuvavanyo lomlomo-lweswekile-ukunyamezeleka kumadoda atyebileyo ngaphambi nasemva kokuphulukana nobunzima. NdinguJ J Clin Nutriti 2004; 80: 22-8. Jonga i-abstract.
93. Umgaqo JD, Barkauskas CE, Surwit RS, Feinglos MN. I-caffeine yonakalisa imetabolism yohlobo lwe-2 lweswekile. Unonophelo lweSwekile 2004; 27: 2047-8. Jonga i-abstract.
94. I-Saldana MD, i-Zetzl C, i-Mohamed RS, i-Brunner G. Ukukhutshwa kwe-methylxanthines ukusuka kwimbewu ye-guarana, amagqabi amaqabane, kunye neembotyi zecocoa zisebenzisa i-carbon dioxide kunye ne-ethanol. J Agric Ukutya Chem 2002; 50: 4820-6. Jonga i-abstract.
95. UAndersen T, uFogh J. Ukwehla kobunzima kunye nokulibaziseka kokukhupha isisu kulandela ukulungiswa kwamayeza ase Mzantsi Melika kwizigulana ezityebe kakhulu. Isidlo seJ Hum esisondlo 2001; 14: 243-50. Jonga i-abstract.
96. U-Esmelindro AA, uGirardi Jdos S, uMossi A, et al. Impembelelo yezinto eziguquguqukayo kwi-agronomic ekwakhiweni kwamagqabi eti (Ilex paraguariensis) izicatshulwa ezifunyenwe kwiziko le-CO2 kwi-30 degrees C kunye ne-175 bar. J Agric Ukutya Chem 2004; 52: 1990-5. Jonga i-abstract.
97. I-Sewram V, De Stefani E, Brennan P, Boffetta P. Ukusetyenziswa kwe-Mate kunye nomngcipheko wesifo somhlaza wesifo se-squamous esophageal e-uruguay. Umhlaza we-Epidemiol Biomarkers Prev 2003; 12: 508-13. Jonga i-abstract.
98. IGoldenberg D, iGolz A, kunye noJoachims HZ. Iqabane lesiselo: umngcipheko womhlaza wentloko nentamo. Intloko yeNtloko 2003; 25: 595-601. Jonga i-abstract.
99. ICannon ME, Cooke CT, McCarthy JS. I-Caffeine-india arrhythmia yentliziyo: ingozi engaziwayo yemveliso yokutya kwezempilo. UMed J Aust 2001; 174: 520-1. Jonga i-abstract.
100. Ixesha elide KL. Imithombo eyaziwayo nefihliweyo ye-caffeine kwiziyobisi, ekutyeni nakwimveliso yendalo. J Ndingu-Pharm Assoc 2002; 42: 625-37. Jonga i-abstract.
101. IDews PB, O'Brien CP, Bergman J. Caffeine: Iziphumo zokuziphatha zokurhoxa kunye nemicimbi ehambelana nayo. Ukutya iChem Toxicol 2002; 40: 1257-61. Jonga i-abstract.
102. IHolmgren P, i-Norden-Pettersson L, i-Ahlner J. Caffeine yokusweleka-iingxelo zamatyala amane. I-Forensic Sci Int 2004; 139: 71-3. Jonga i-abstract.
103. UChou T. Vuka kwaye unuke ikofu. Caffeine, ikofu, kunye neziphumo zonyango. INtshona J Med 1992; 157: 544-53. Jonga i-abstract.
104. IHowell LL, iCoffin VL, iSpealman RD. Ukuziphatha kunye nefuthe lomzimba le-xanthines kwizidalwa ezingezizo ezomntu. I-Psychopharmacology (Berl) 1997; 129: 1-14. Jonga i-abstract.
105. Iziko lezeMpilo. I-Caffeine yoLondolozo lweNtsebenzo yeNgqondo yokuSebenza: Iifom zokuSebenza koMkhosi. IWashington, DC: I-National Academy Press, 2001. Iyafumaneka apha: http://books.nap.edu/books/0309082587/html/index.html.
106. UZheng XM, uWilliam RC. Amanqanaba e-caffeine ye-serum emva kokungabikho kweyure ye-24: iimpembelelo zeklinikhi kwi-dipyridamole Tl ye-myocardial imaging perfusion. J Nucl Med Technol 2002; 30: 123-7. Jonga i-abstract.
107. I-Aqel RA, iZoghbi GJ, iTrimm JR, et al. Iziphumo zecaffeine elawulwa ngaphakathi ngaphakathi ngaphakathi kwi-adenosine-eyanyanzeliswa yi-coronary hemodynamics kwizigulana ezinesifo semithambo. NdinguJ Cardiol 2004; 93: 343-6. Jonga i-abstract.
108. Ngaphantsi kwe-DA. Ngawaphi amayeza ekufuneka abanjwe ngaphambi kovavanyo lwe-pharmacologic okanye lovavanyo lokuzivocavoca? Iklinikhi yokuCoca uJ Med 2002; 69: 449-50. Jonga i-abstract.
109. USmith A.Iziphumo zecaffeine ekuziphatheni komntu. Ukutya kweKhem Toxicol 2002; 40: 1243-55. Jonga i-abstract.
110. UStanek EJ, uMelko GP, uCharland SL. Ukuphazamiseka kweXanthine nge-dipyridamole-thallium-201 imaging ye-myocardial. Unyango ngo-1995; 29: 425-7. Jonga i-abstract.
111. UCarrillo JA, uBenitez J.Ukusebenzisana kweekhemikhali phakathi kwecafine yokutya kunye namayeza. Kwiiklinikhi zeFarmacokinet 2000; 39: 127-53. Jonga i-abstract.
112. I-Wahllander A, Paumgartner G. Iziphumo ze-ketoconazole kunye ne-terbinafine kwi-pharmacokinetics ye-caffeine kumavolontiya asempilweni. I-Eur J Clin Pharmacol 1989; 37: 279-83. Jonga i-abstract.
113. USanderink GJ, uBournique B, uStevens J, et al. Ukubandakanyeka kwe-CYP1A isoenzymes yomntu kwimetabolism kunye nokunxibelelana kweziyobisi kwe-riluzole in vitro. I-Pharmacol Exp Ther 1997; 282: 1465-72. Jonga i-abstract.
114. I-Brown NJ, i-Ryder D, i-RA yesebe. Unxibelelwano lwe-pharmacodynamic phakathi kwe-caffeine kunye ne-phenylpropanolamine. KwiKlinikhi ye-Pharmacol Ther 1991; 50: 363-71. Jonga i-abstract.
115. I-Abernethy DR, Todd EL. Ukuphazamiseka kwendlela yokucoca i-caffeine ngokusetyenziswa okungapheliyo kweedosi ezisezantsi ezine-contraceptive zomlomo. I-Eur J Clin Pharmacol 1985; 28: 425-8. Jonga i-abstract.
116. NgoMeyi DC, uJarboe CH, uVanBakel AB, uWilliam WM. Iziphumo ze-cimetidine kwindawo ye-caffeine kubantu abatshayayo nakwabo bangatshayiyo. KwiKlinikhi ye-Pharmacol Ther 1982; 31: 656-61. Jonga i-abstract.
117. UNawrot P, iJordani S, i-Eastwood J, et al. Iziphumo zecaffeine kwimpilo yabantu. Ukongezwa kokutya kwiContam 2003; 20: 1-30. Jonga i-abstract.
118. IMassey LK, iWhiting SJ. I-caffeine, i-calcium yokuchama, i-calcium metabolism kunye nethambo. J Amanqatha 1993; 123: 1611-4. Jonga i-abstract.
119. I-Infante S, iBaeza ML, iCalvo M, okqhubekayo. I-Anaphylaxis ngenxa ye-caffeine. Ukunyuka komzimba ngo-2003; 58: 681-2. Jonga i-abstract.
120. UNix D, uZelenitsky S, uSymonds W, et al. Iziphumo zefluconazole kwi-pharmacokinetics ye-caffeine kwizifundo ezincinci nezindala. Kwiklinikhi ye-Pharmacol Ther 1992; 51: 183.
121. IKockler DR, uMcCarthy MW, uLawson CL. Umsebenzi wokubamba kunye nokungaphenduli emva kokungenisa i-hydroxycut. I-Pharmacotherapy 2001; 21: 647-51 .. Jonga i-abstract.
122. IGrandjean AC, iReimers KJ, iBannick KE, iHaven MC. Iziphumo ze-caffeine, ezingenayo i-caffeine, i-caloric kunye ne-non-caloric iziyobisi kwi-hydration. J NdinguColl Nutriti 2000; 19: 591-600 .. Jonga i-abstract.
123. UDreher HM. Iziphumo zokuncitshiswa kwe-caffeine kumgangatho wokulala kunye nokuba sempilweni kwabantu abane-HIV. J Psychosom Res 2003; 54: 191-8 .. Jonga okungafakwanga.
124. IMassey LK. Ngaba icaffeine ingumngcipheko wokulahleka kwethambo kubantu abadala? NdinguJ J Clin Nutr 2001; 74: 569-70. Jonga i-abstract.
125. UMcGowan JD, Altman RE, Kanto WP Jr.Iimpawu zokurhoxa kweNeonatal emva kokungena komama okungapheliyo kwecaffeine. UMzantsi Med J 1988; 81: 1092-4 .. Jonga okungafakwanga.
126. IBara AI, iBarley EA. Caffeine yesifuba. Isiseko sedatha yeCochrane Syst Rev 2001; 4: CD001112 .. Jonga i-abstract.
127. IPorner NK, iLampe JW. Iindlela ezinokubakho zonyango lokutya kwiimeko zebele le-fibrocystic zibonisa ubungqina obungonelanga bokusebenza. J Nditya i-Assoc 2000; 100: 1368-80. Jonga i-abstract.
128. I-Bell DG, i-Jacobs I, i-Ellerington K. Iziphumo ze-caffeine kunye ne-ephedrine yokungenisa ukusebenza kwe-anaerobic. Ukuzivocavoca kweMed Sci Exerc 2001; 33: 1399-403. Jonga i-abstract.
129. I-Avisar R, i-Avisar E, i-Weinberger D. Iziphumo zokusetyenziswa kwekofu kuxinzelelo lwe-intraocular. UAnn Pharmacother 2002; 36: 992-5 .. Jonga i-abstract.
130. UFerrini RL, uBarrett-Connor E.Icaffeine yokutya kunye nenqanaba lesini le-steroid elingapheliyo kubafazi be-postmenopausal. Isifundo seRancho Bernardo. NdinguJ Epidemiol 1996: 144: 642-4. Jonga i-abstract.
131. UArdlie NG, uGlew G, uSchultz BG, uSchwartz CJ. Inhibition kunye nokubuyiselwa umva kweplatelet aggregation yi-methyl xanthines. UTromb Diath Haemorrh 1967; 18: 670-3. Jonga i-abstract.
132. UAli M, Afzal M. Isithinteli esinamandla se-thrombin evuselelekileyo yeplatelet thromboxane ekwakhiweni kweti engagqitywanga. Iprostaglandins Leukot Med 1987; 27: 9-13. Jonga i-abstract.
133. IHallerle CA, iBenowitz NL. Iziganeko zenkqubo ye-cardiovascular and central system ehambelana nezongezelelo zokutya eziqukethe i-ephedra alkaloids. N Engl J Med 2000; 343: 1833-8. Jonga i-abstract.
134. USinclair CJ, uGiiger JD. Ukusetyenziswa kweCaffeine kwezemidlalo. Uphengululo lwekhemesti. J Ezemidlalo ngokuDinwa komzimba 2000; 40: 71-9. Jonga i-abstract.
135. IAmerican Academy yeZilwanyana. Ukuhanjiswa kweziyobisi kunye nezinye iikhemikhali kubisi lomntu. Iipedatifikethi 2001; 108: 776-89. Jonga i-abstract.
136. ULloyd T, uJohnson-Rollings N, uEggli DF, et al. Ubume bethambo phakathi kwabafazi abasemva kwemiphefumlo abanendlela eyahlukeneyo yokuthatha ikhaffeine: uphando olude. J Ndingu-Coll Nutrut 2000; 19: 256-61. Jonga i-abstract.
137. UWatson JM, uJenkins EJ, uHamilton P, et al. Impembelelo ye-caffeine kwisantya kunye nokuqonda kwe-hypoglycemia kwizigulana ezihlala simahla ezine-1 yeswekile. Unonophelo lweSwekile 2000; 23: 455-9. Jonga i-abstract.
138. Umgaqo weCW, Avila JR. Incwadana yobungcali yamaYeza aQinisekisiweyo kunye naManye amayeza. Umhla woku-1. I-Springhouse, PA: I-Springhouse Corp., 1999.
139. UMcGee J, uPatrick RS, iWood CB, iBlumgart LH. Ityala lesifo se-veno-occlusive sesibindi eBritane esinxulunyaniswa nokusetyenziswa kweti ye-herbal. J Ikliniki yePathol 1976; 29: 788-94. Jonga i-abstract.
140. IHagg S, Spigset O, Mjorndal T, Dahlqvist R. Iziphumo zecaffeine kwi-clozapine pharmacokinetics kumavolontiya asempilweni. UBr J Clin Pharmacol 2000; 49: 59-63. Jonga i-abstract.
141. UWilliam MH, isebe JD. Yenza ukuxhaswa kunye nokusebenza komsebenzi: ukuhlaziywa. NdinguColl Nutriti 1998; 17: 216-34. Jonga i-abstract.
142. I-FDA. Umgaqo ocetywayo: izongezo zokutya eziqukethe i-ephedrine alkaloids. Ifumaneka kwi: www.verity.fda.gov (Ifumaneka nge-25 Januwari 2000).
143. UDews PB, uC Curtis GL, uHanford KJ, u-O'Brien CP. Ukuphindaphindeka kokurhoxiswa kwe-caffeine kuvavanyo olusekwe kubemi nakwilingo elilawulwayo, elingaboniyo. J Clin Pharmacol 1999; 39: 1221-32. Jonga i-abstract.
144. INurminen ML, Niittynen L, Korpela R, Vapaatalo H. Ikofu, icaffeine kunye noxinzelelo lwegazi: uphononongo olunzulu. I-Eur J yeKlinikhi yeNutrig 1999; 53: 831-9. Jonga i-abstract.
145. UDiPiro JT, uTalbert RL, uYe GC, et al; ii-eds. I-Pharmacotherapy: Indlela ye-pathophysiologic. Ngomhla we-4. IStamford, CT: IAppleton kunye neLange, 1999.
146. IPollock BG, uWylie M, uStack JA, et al. Ukuthintela i-caffeine metabolism ngonyango lwe-estrogen endaweni yabasetyhini abasemva kwemasopaopausal. J Clin Pharmacol 1999; 39: 936-40. Jonga i-abstract.
147. I-Wemple RD, iMvana DR, McKeever KH. I-Caffeine vs i-caffeine -simahla iziselo zemidlalo: Iziphumo kwimveliso yokuchama ekuphumleni nasekuzilolongeni ixesha elide. I-Int J Sports Med 1997; 18: 40-6. Jonga i-abstract.
148. IStookey JD. Iziphumo zokuchama kotywala kunye necaffeine kunye nokungeniswa kwamanzi ngokungagungqiyo. I-Eur J Epidemiol 1999; 15: 181-8. Jonga i-abstract.
149. UFernandes O, uSabharwal M, uSmiley T, et al.Ukumodareyitha ukuya ekusetyenzisweni kakhulu kwecaffeine ngexesha lokukhulelwa kunye nokunxibelelana nokuqhomfa okuzenzekelayo kunye nokukhula okungaqhelekanga komntwana: uhlalutyo lweemeta. Ukuhlaziya iTyhefu ka-1998; 12: 435-44. Jonga i-abstract.
150. UKlebanoff MA, uLeviine RJ, uDerSimonian R, et al. I-serum paraxanthine yoomama, i-caffeine metabolite, kunye nomngcipheko wokuqhomfa okuzenzekelayo. U-Eng Eng J Med 1999; 341: 1639-44. Jonga i-abstract.
151. Inkqubo yeSizwe yetyhefu (NTP). Icaffeine. Iziko loVavanyo loMngcipheko kuKwenziwa ngokutsha kwaBantu (CERHR). Ifumaneka kwi: http://cerhr.niehs.nih.gov/common/caffeine.html.
152. URapuri PB, uGallagher JC, uKinyamu HK, uRyschon KL. Ukutya kweCaffeine kunyusa inqanaba lokulahleka kwethambo kubafazi abadala kwaye kunxibelelana ne-vitamin D receptor genotypes. NdinguJ J Clin Nutr 2001; 74: 694-700. Jonga i-abstract.
153. UChiu KM. Ukusebenza kwe-calcium yongeza kwisithambo kubasetyhini abase-postmenopausal. J Gerontol A Biol Sci Med Sci 1999; 54: M275-80. Jonga i-abstract.
154. UVandeberghe K, uGillis N, uVan Leemputte M, et al. I-caffeine ichasene nesenzo se-ergogenic yokulayisha ukulayishwa kwezihlunu. J Appl uPhysiol 1996; 80: 452-7. Jonga i-abstract.
155. Ukutolikwa koVavanyo lovavanyo. Isishwankathelo seLebhu yelebhu. Eyesihlanu ed; IBoston, MA: Encinci kaBrown, ngo-1992.
156. UDe Stefani E, uFierro L, uCorrea P, et al. Ukusela amaqabane kunye nomngcipheko womhlaza wemiphunga emadodeni: isifundo solawulo lwamatyala esivela eUruguay. Umhlaza we-Epidemiol Biomarkers Prev 1996; 5: 515-9. Jonga i-abstract.
157. UDe Stefani E, uCorrea P, uFierro L, et al. Icuba elimnyama, iqabane, kunye nomhlaza wesinyi. Isifundo solawulo lwamatyala esivela eUruguay. Umhlaza 1991; 67: 536-40. Jonga i-abstract.
158. UDe Stefani E, uFierro L, uMendilaharsu M, et al. Ukutya inyama, 'ukusela' iqabane kunye nomhlaza weeseli e-Uruguay: isifundo solawulo lwamatyala. Br J Umhlaza 1998; 78: 1239-43. Jonga i-abstract.
159. UPintos J, uFranco EL, uOliveira BV, et al. I-Mate, ikofu, kunye nokusetyenziswa kweti kunye nomngcipheko womhlaza womgaqo ongaphezulu we-aerodigestive emazantsi eBrazil. Epidemiology 1994; 5: 583-90. Jonga i-abstract.
160. IHodgson JM, iPuddey IB, uBurke V, et al. Iziphumo kuxinzelelo lwegazi lokusela iti eluhlaza kunye emnyama. J Hypertens 1999; 17: 457-63 (PubMed) (Umnqamlezo) Jonga i-abstract.
161. Wakabayashi K, Kono S, Shinchi K, okqhubekayo. Ukusetyenziswa kwesiqhelo kwekofu kunye noxinzelelo lwegazi: Uphononongo lwamagosa okuzikhusela eJapan. I-Eur J Epidemiol 1998; 14: 669-73. Jonga i-abstract.
162. Kwidayethi, Phantse iLahleko yokuGqibela. IWashington Post. Ifumaneka kwi: http://www.washingtonpost.com/archive/politics/2000/03/19/for-dieter-nearly-the-ultimate-loss/c0f07474-489d-4f44-bc17-1f1367c956ae/ (Ifumaneka nge-19 Matshi 2000 ).
163. UVahedi K, uDomingo V, uAmarenco P, uBousser MG. Ischemic stroke kwimbaleki esebenzise i-MaHuang isicatshulwa kunye nokudala i-monohydrate yokwakha umzimba. J Neurolurosuroski yengqondo 2000; 68: 112-3. Jonga i-abstract.
164. UJoeres R, uKlinker H, uHeusler H, et al. Impembelelo ye-mexiletine ekupheliseni i-caffeine. IPhemacol Ther 1987; 33: 163-9. Jonga i-abstract.
165. IHsu CK, uLeo P, uShastry D, et al. Ityhefu ye-Anticholinergic enxulunyaniswa neti yemifuno. IArch Intern Med 1995; 155: 2245-8. Jonga i-abstract.
166. IHealy DP, iPolk RE, iKanawati L, et al. Ukusebenzisana phakathi komlomo we-ciprofloxacin kunye ne-caffeine kumavolontiya aqhelekileyo. Iiarhente zeAntimicrob Chemother 1989; 33: 474-8. Jonga i-abstract.
167. UCarbo M, uSegura J, uDe la Torre R, okqhubekayo. Iziphumo zequinolones ekubekweni kwe-caffeine. KwiKlinikhi ye-Pharmacol Ther 1989; 45: 234-40. Jonga i-abstract.
168. I-Harder S, i-Fuhr U, i-Staib AH, i-Wolff T.I-Ciprofloxacin-caffeine: Unxibelelwano lweziyobisi olusekwe kusetyenziswa i-vivo kunye nophando lwe-vitro. NdinguJ Med 1989; 87: 89S-91S. Jonga i-abstract.
169. UMorris JC, Beeley L, Ballantine N. Ukudibana kwe-ethinyloestradiol kunye ne-ascorbic acid kwindoda [ileta]. Br Med J (Iiklinikhi Res Ed) 1981; 283: 503. Jonga i-abstract.
170. IGotz V, uRomankiewicz JA, uMoss J, uMurray HW. Prophylaxis ngokuchasene ne-ampicillin enxulumene nesifo sorhudo kunye nokulungiselela i-lactobacillus. NdinguJ Hosp Pharm 1979; 36: 754-7. Jonga i-abstract.
171. I-Shearer MJ, i-Bach A, i-Kohlmeier M. Chemistry, imithombo yesondlo, ukuhanjiswa kwezicubu kunye ne-metabolism ye-vitamin K ngokubhekisele ngokukodwa kwimpilo yethambo. J Amanqatha 1996; 126: 1181S-6S. Jonga i-abstract.
172. UMcEvoy GK, ed. Ulwazi lwe-AHFS yeziyobisi. I-Bethesda, MD: Umbutho waseMelika we-Health-System Pharmacists, 1998.
173. Uphengululo lweeMveliso zeNdalo ngamaNqaku kunye nokuThelekisa. ILouis, MO: iWolters Kluwer Co., 1999.
174. Blumenthal M, ed. IKhomishini epheleleyo yaseJamani i-E Monographs: Isikhokelo sonyango kumaYeza eHerbal. Dlulisa. S. Klein. IBoston, MA: IBhunga laseMelika leBhotani, i-1998.

Ukuhlaziywa kokugqibela-06/04/2019